QUOTE AND NEWS
Cloud Computing  Apr 30  Comment 
La plate-forme cloud de Medidata Solutions (NASDAQ : MDSO) a été sélectionnée par Auris Medical, une société pharmaceutique suisse axée sur le développement de nouvelles thérapies visant à soigner les troubles de...
Cloud Computing  Apr 30  Comment 
Die Cloud-Plattform von Medidata Solutions’ (NASDAQ: MDSO) wurde von Auris Medical, einem schweizerischen Pharmaunternehmen, das auf die Entwicklung neuer Therapien bei Innenohrerkrankungen spezialisiert ist, ...
Samurai Trader  Apr 29  Comment 
MDSO was on my price relative watch list today, and was the only stock to break out. It recently pulled back to the 50dma, but there were a couple of problems: for one, I like to get stocks that are pulling back to he 50dma whiel the market is...
StreetInsider.com  Apr 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Medidata+Solutions%2C+Inc.+%28MDSO%29+Tops+Q1+EPS+by+12c%3B+Guides+Q2%2C+FY13+Revs/8284071.html for the full story.
Cloud Computing  Apr 29  Comment 
Medidata Solutions (NASDAQ: MDSO), the leading global provider of cloud-based solutions for the life sciences industry, today announced its financial results for the first quarter 2013 and provided detailed financial ...
Cloud Computing  Mar 19  Comment 
PharmaMar , una empresa biofarmacéutica española, ha elegido Medidata Solutions (NASDAQ: MDSO) por sus soluciones líderes del sector en captura electrónica de datos (EDC en sus siglas en inglés) y gestión de...
StreetInsider.com  Feb 21  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Medidata+Solutions%2C+Inc.+%28MDSO%29+Tops+Q4+EPS+by+7c%3B+Guides+Sales+Above+the+Street/8118917.html for the full story.
Cloud Computing  Feb 21  Comment 
Medidata Solutions (NASDAQ: MDSO), a leading global provider of cloud-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the fourth quarter...
Cloud Computing  Feb 15  Comment 
Medidata Solutions (NASDAQ: MDSO), a leading global provider of cloud-based clinical development solutions, today announced that Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will ...




RELATED WIKI ARTICLES
 
TOP CONTRIBUTORS
Medidata Solutions (NASDAQ:MDSO) sells a software platform called Medidata Rave that helps biotech and pharmaceutical companies enhance the efficiency of their clinical development processes.[1] It achieves this by integrating electronic data capture (EDC) with a clinical data management system (CDMS) in a single product.
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/f/f1/2698.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/f/f1/2698.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/f/f1/2698.png/250px-2698.png' @ convert.c/ConvertImageCommand/2800.
Medidata Rave is a comprehensive platform that replaces traditional paper-based methods of capturing and managing clinical data.
The company also sells a protocol authoring tool (Medidata Designer), a grant management system (Medidata Grant Manager) and a CRO contracting platform (Medidata CRO Contractor). In 2007, 2008 and the first quarter of 2009, the company's top five customers by revenue were Johnson & Johnson, AstraZeneca, Amgen, Astellas Pharma and Takeda Pharmaceutical.[1]

Medidata's initial public offering (IPO) of stock is scheduled for 18 June 2009. It plans to sell 6.3 million shares at between $11 and $12 per share. In 2008, the company had $106 million in total revenues, up 67.9% from $63.0 million in 2007. However, it still made a net loss of $18.3 million, down 22.8% from the $23.7 million net loss made in 2007.[2] In the same year, 69% of revenues came from customers in the United States, 21% from Europe and 10% from Asia (including Australia). In the first quarter of 2009, the company had $33.6 million in total revenues, up 60.2% from $21.0 million in the same quarter of the 2008.[2] It also had $1.7 million in net income, up 120% from the $8.6 million net loss made in 2007. Existing investors in the company include Insight Venture Partners (33.9%), chief executive officer and chairman Tarek Sherif (9.0%), president and director Glen M. de Vries (9.0%) and Milestone Venture Partners (7.6%).

References

  1. 1.0 1.1 Business, 2009 MDSO S-1/A
  2. 2.0 2.1 Selected Consolidated Financial Information, 2009 MDSO S-1/A
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki